PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States.\', \'Department of Immunology, St Jude Children\'s Research Hospital, Memphis, United States.\', \'Department of Industrial Engineering and Management, Ben-Gurion University of the Negev, Be\'er Sheva, Israel.\', \'St Jude Children\'s Research Hospital, Memphis, United States.\', \'Shraga Segal Department of Microbiology and Immunology, Ben-Gurion University of the Negev, Be\'er Sheva, United States.\', \'Fred Hutchinson Cancer Research Center, Seattle, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7554/eLife.68605e68605
?:doi
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 34845983
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • TCR meta-clonotypes for biomarker discovery with tcrdist3 enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all